Renal Cancer - Results from #3920

Focal Ablative Therapy for Renal Cell Carcinoma in Transplant Allograft Kidneys. December 21, 2018

The Association Between Ascorbate and the Hypoxia-Inducible Factors in Human Renal Cell Carcinoma Requires a Functional Von Hippel-Lindau Protein. December 20, 2018

Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease. December 20, 2018

Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinoma. December 20, 2018

Predictors of disease aggressiveness influence outcome from immunotherapy treatment in renal clear cell carcinoma. December 20, 2018

Evolving landscape of the treatment of metastatic clear cell renal cell carcinoma. December 20, 2018

Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial. December 20, 2018

Tumor-to-Tumor Metastasis - a Unique Case of Clear Cell Renal Cell Carcinoma Harboring Metastasis of Adenocarcinoma of Unknown Origin. December 20, 2018

Association of hypoxia-inducible factor-1 alpha gene polymorphism with renal cell carcinoma susceptibility. December 20, 2018

TRIM2 downregulation in clear cell renal cell carcinoma affects cell proliferation, migration, and invasion and predicts poor patients' survival. December 20, 2018

Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre. December 19, 2018

Emerging immunotherapies for autoimmune kidney disease. December 19, 2018

Ablation therapy for renal cell cancer of elderly patients. December 19, 2018

Surgical therapy for the elderly patients with renal cell carcinoma. December 19, 2018

Role of miR-486-5p in regulating renal cell carcinoma cell proliferation and apoptosis via TGF-β-activated kinase 1. December 18, 2018

Nephrectomy for Metastatic Kidney Tumor in Patients with Differentiated Thyroid Cancer: A Report of Two Cases. December 18, 2018

In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. December 18, 2018

SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11). December 18, 2018

Individualized Dosing of Axitinib Based on First-Dose Area Under the Concentration-Time Curve for Metastatic Renal-Cell Carcinoma. December 18, 2018

Symptomatic treatment of brain metastases in renal cell carcinoma with sorafenib. December 17, 2018

Page 197 of 456